Style | Citing Format |
---|---|
MLA | Shamsnia HS, et al.. "Pathogenesis, Treatments, and Challenges Associated With Malaria and Nanomedicines for Antimalarial Therapy." Advances in Antiparasitic Therapies and Drug Delivery, vol. , no. , 2023, pp. 153-160. |
APA | Shamsnia HS, Hosseini Y, Niknejad AH, Momtaz S, Abdolghaffari AH, Jamialahmadi T, Sahebkar A (2023). Pathogenesis, Treatments, and Challenges Associated With Malaria and Nanomedicines for Antimalarial Therapy. Advances in Antiparasitic Therapies and Drug Delivery, (), 153-160. |
Chicago | Shamsnia HS, Hosseini Y, Niknejad AH, Momtaz S, Abdolghaffari AH, Jamialahmadi T, Sahebkar A. "Pathogenesis, Treatments, and Challenges Associated With Malaria and Nanomedicines for Antimalarial Therapy." Advances in Antiparasitic Therapies and Drug Delivery , no. (2023): 153-160. |
Harvard | Shamsnia HS et al. (2023) 'Pathogenesis, Treatments, and Challenges Associated With Malaria and Nanomedicines for Antimalarial Therapy', Advances in Antiparasitic Therapies and Drug Delivery, (), pp. 153-160. |
Vancouver | Shamsnia HS, Hosseini Y, Niknejad AH, Momtaz S, Abdolghaffari AH, Jamialahmadi T, et al.. Pathogenesis, Treatments, and Challenges Associated With Malaria and Nanomedicines for Antimalarial Therapy. Advances in Antiparasitic Therapies and Drug Delivery. 2023;():153-160. |
BibTex | @article{ author = {Shamsnia HS and Hosseini Y and Niknejad AH and Momtaz S and Abdolghaffari AH and Jamialahmadi T and Sahebkar A}, title = {Pathogenesis, Treatments, and Challenges Associated With Malaria and Nanomedicines for Antimalarial Therapy}, journal = {Advances in Antiparasitic Therapies and Drug Delivery}, volume = {}, number = {}, pages = {153-160}, year = {2023} } |
RIS | TY - JOUR AU - Shamsnia HS AU - Hosseini Y AU - Niknejad AH AU - Momtaz S AU - Abdolghaffari AH AU - Jamialahmadi T AU - Sahebkar A TI - Pathogenesis, Treatments, and Challenges Associated With Malaria and Nanomedicines for Antimalarial Therapy JO - Advances in Antiparasitic Therapies and Drug Delivery VL - IS - SP - 153 EP - 160 PY - 2023 ER - |